Skip to content
Subscriber Only

EU, Gilead Reach Deal on Supply of Antiviral Drug Remdesivir

  • 63 million-euro contract for treatment of Covid-19 patients
  • Deal also ensures antiviral treatment’s supplies for the U.K.
One vial of  Remdesivir.

One vial of  Remdesivir.

Photographer: Ulrich Perrey/AFP via Getty Images

Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.

The European Union reached an agreement with Gilead Sciences Inc. for supplies of the company’s antiviral drug remdesivir to combat the coronavirus.